Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts (Q46679091)
Jump to navigation
Jump to search
scientific article published in October 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts |
scientific article published in October 1998 |
Statements
1 reference
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts (English)
1 reference
DeNardo GL
1 reference
Kroger LA
1 reference
Meares CF
1 reference
Richman CM
1 reference
Salako Q
1 reference
Shen S
1 reference
Lamborn KR
1 reference
Peterson JJ
1 reference
Miers LA
1 reference
Zhong GR
1 reference
DeNardo SJ
1 reference
1 October 1998
1 reference
4
1 reference
10
1 reference
2483-2490
1 reference